Investing IdeasBrowse All StocksMarkets
Have your own idea? Try our Stock Screener
Header cover image

Danish (OMX) Market Analysis & Valuation

UpdatedJun 09, 2026
DataAggregated Company Financials
Companies129
  • 7D-1.7%
  • 3M3.9%
  • 1Y-21.3%
  • YTD-7.0%

Over the last 7 days, the market has dropped 1.7%, driven by a pullback of 3.7% in the Healthcare sector. As for last year, the market is also down 21%. As for the next few years, earnings are expected to grow by 9.3% per annum.

Trending IndustriesBiotech

Market Valuation and Performance

Has the Danish Market valuation changed over the past few years?

DateMarket CapRevenueEarningsPEAbsolute PEPS
Wed, 10 Jun 2026DKK 3.9tDKK 2.1tDKK 245.5b16.6x15.8x1.9x
Fri, 08 May 2026DKK 4.0tDKK 2.0tDKK 256.0b16.2x15.6x2x
Sun, 05 Apr 2026DKK 3.7tDKK 2.0tDKK 237.6b15.3x15.7x1.9x
Tue, 03 Mar 2026DKK 3.8tDKK 2.0tDKK 237.8b16.7x15.9x1.9x
Thu, 29 Jan 2026DKK 4.5tDKK 1.9tDKK 260.3b16.8x17.2x2.3x
Sat, 27 Dec 2025DKK 4.2tDKK 1.9tDKK 260.5b16.2x16x2.1x
Mon, 24 Nov 2025DKK 3.9tDKK 2.0tDKK 262.5b14.8x14.9x2x
Wed, 22 Oct 2025DKK 4.2tDKK 1.9tDKK 287.8b15.1x14.4x2.1x
Fri, 19 Sep 2025DKK 4.1tDKK 1.9tDKK 287.0b15.3x14.5x2.2x
Sun, 17 Aug 2025DKK 3.9tDKK 1.9tDKK 280.3b14.8x13.8x2x
Tue, 15 Jul 2025DKK 4.4tDKK 1.9tDKK 262.0b15.8x16.8x2.4x
Thu, 12 Jun 2025DKK 4.8tDKK 1.9tDKK 263.0b15.8x18.4x2.6x
Sat, 10 May 2025DKK 4.4tDKK 1.9tDKK 266.9b15.1x16.3x2.3x
Mon, 07 Apr 2025DKK 4.1tDKK 1.9tDKK 260.3b13x15.8x2.2x
Wed, 05 Mar 2025DKK 5.3tDKK 1.9tDKK 263.2b13.8x20x2.8x
Fri, 31 Jan 2025DKK 5.2tDKK 1.8tDKK 238.1b14.1x21.7x2.8x
Sun, 29 Dec 2024DKK 5.3tDKK 1.8tDKK 238.2b13.9x22.4x2.9x
Tue, 26 Nov 2024DKK 5.8tDKK 1.8tDKK 237.6b14.6x24.5x3.2x
Thu, 24 Oct 2024DKK 6.1tDKK 1.7tDKK 180.2b15.2x33.7x3.5x
Sat, 21 Sep 2024DKK 6.4tDKK 1.7tDKK 180.0b16.1x35.5x3.7x
Mon, 19 Aug 2024DKK 6.6tDKK 1.7tDKK 180.2b16.8x36.8x3.8x
Wed, 17 Jul 2024DKK 6.8tDKK 1.7tDKK 185.3b15.6x36.9x4x
Fri, 14 Jun 2024DKK 7.0tDKK 1.7tDKK 184.7b15.5x37.7x4.1x
Sun, 12 May 2024DKK 6.5tDKK 1.7tDKK 183.8b14.7x35.1x3.8x
Tue, 09 Apr 2024DKK 6.4tDKK 1.7tDKK 192.3b15x33.2x3.7x
Thu, 07 Mar 2024DKK 6.3tDKK 1.7tDKK 191.8b13.2x32.7x3.7x
Sat, 03 Feb 2024DKK 6.0tDKK 1.8tDKK 225.0b14.1x26.5x3.3x
Mon, 01 Jan 2024DKK 5.5tDKK 1.8tDKK 216.0b14.2x25.7x3.1x
Wed, 29 Nov 2023DKK 5.3tDKK 1.8tDKK 216.1b13.2x24.7x3x
Fri, 27 Oct 2023DKK 5.2tDKK 1.9tDKK 284.4b12.4x18.3x2.8x
Sun, 24 Sep 2023DKK 5.3tDKK 1.9tDKK 283.7b13.1x18.6x2.8x
Tue, 22 Aug 2023DKK 5.3tDKK 1.9tDKK 281.2b13.3x18.7x2.8x
Thu, 20 Jul 2023DKK 5.0tDKK 1.9tDKK 318.4b13.4x15.8x2.6x
Sat, 17 Jun 2023DKK 5.2tDKK 1.9tDKK 322.1b13.8x16x2.7x
Price to Earnings Ratio

16x


Total Market Cap: DKK 5.2tTotal Earnings: DKK 322.1bTotal Revenue: DKK 1.9tTotal Market Cap vs Earnings and Revenue0%0%0%
Danish Market Price to Earnings3Y Average 22.4x202420252026
Current Market PE
  • Investors are pessimistic on the Danish market, indicating that they anticipate earnings will not grow as fast as they have historically.
  • The market is trading at a PE ratio of 15.9x which is lower than its 3-year average PE of 22.4x.
Past Earnings Growth
  • The earnings for Danish listed companies have declined 8.7% per year over the last three years.
  • Meanwhile revenues have been flat.
  • This means that either the cost of doing business or the level of investment back into businesses is increasing since sales have remained steady while profits have fallen.

Sector Trends

Which sectors have driven the changes within the Danish Market?

DK Market-1.71%
Energy3.55%
Consumer Discretionary2.41%
Industrials1.23%
Real Estate1.00%
Tech-0.18%
Financials-1.26%
Telecom-1.64%
Consumer Staples-1.91%
Materials-2.04%
Utilities-3.37%
Healthcare-3.68%
Sector PE
  • Investors favour the Tech sector the most for future growth, which is trading close to its 3-year average PE ratio of 55.3x.
    • The market's confidence is likely because analysts are expecting annual earnings growth of 36.4% which is higher than its past year's earnings decline of 33.5% per year.
Forecasted Growth
  • Analysts are most optimistic on the Tech sector, expecting annual earnings growth of 36% over the next 5 years.
  • This is better than its past earnings decline of 33% per year.
  • In contrast, the Energy sector is expected to see its earnings decline by 36% per year over the next few years.

Top Stock Gainers and Losers

Which companies have driven the market over the last 7 days?

CompanyLast Price7D1YValuationSector
MAERSK B A.P. Møller - MærskDKK 17.28k6.0%
+DKK 14.1b		42.8%PE23.9xIndustrials
NSIS B NovozymesDKK 383.603.3%
+DKK 5.7b		-20.6%PE40.1xMaterials
GMAB GenmabDKK 1.61k4.3%
+DKK 4.1b		7.7%PE18.6xHealthcare
PNDORA PandoraDKK 616.005.4%
+DKK 2.2b		-48.0%PE8.6xConsumer Discretionary
COLO B ColoplastDKK 386.702.3%
+DKK 2.0b		-39.3%PE41.3xHealthcare
See more

Market Insights

Header cover image
The most anticipated IPO in history lands next week at an expected $1.75 trillion price tag. Part launch business, part Starlink, and increasingly an AI bet — could the SpaceX IPO be carrying a valuation that has no room for error?
Continue reading
Land of the rising yields 📈

Latest News

MAERSK B
DKK 17,280.00
A.P. Møller - Mærsk
7D
6.0%
1Y
42.8%
NOVO B
DKK 269.50
Novo Nordisk
7D
-2.9%
1Y
-48.2%
DANSKE
DKK 329.40
Danske Bank
7D
-0.6%
1Y
27.9%
ZEAL
DKK 278.90
Zealand Pharma
7D
-8.5%
1Y
-43.9%
DSV
DKK 1,557.00
DSV
7D
-4.4%
1Y
-4.4%
Narrative Update • Jun 07

DSV: Schenker Synergies And Moerdijk Expansion Will Support Future Repricing Potential

Narrative Update The analyst price target for DSV is now set at DKK 2,047.80, a change of DKK 5.25. Analysts point to a series of recent target increases in the DKK 1,782 to DKK 2,200 range and generally supportive views on the stock as the key drivers of this adjustment.
HLUN B
DKK 43.00
H. Lundbeck
7D
-2.8%
1Y
8.0%
Narrative Update • Jun 06

HLUN B: Softer Revenue Outlook Will Weigh On Future Earnings Multiple

Analysts now keep their DKK 34.00 price target for H. Lundbeck unchanged, citing a slightly higher assumed discount rate, softer revenue growth, and firmer profit margin and future P/E expectations in their models.
DEMANT
DKK 256.00
Demant
7D
2.6%
1Y
-7.9%
Narrative Update • Jun 05

DEMANT: Raised Fair Value And EU AI Rules May Shape Re Rating

Analysts have lifted the fair value estimate for Demant from DKK 229.83 to DKK 240.32. This reflects updated targets from firms such as Deutsche Bank and Morgan Stanley and is supported by assumptions for slightly higher revenue growth, improved profit margins, and a modestly lower discount rate, while keeping future P/E expectations broadly unchanged.
VWS
DKK 168.90
Vestas Wind Systems
7D
-4.6%
1Y
53.1%
Narrative Update • Jun 04

VWS: Premium P/E Repricing Will Reflect Execution On Orders And Margin Profile

The Analyst Price Target on Vestas Wind Systems is adjusted slightly to DKK 196. Analysts cite updated assumptions on discount rates, revenue growth and profit margins, along with recent Street research that includes both target increases and rating changes.
NKT
DKK 995.00
NKT
7D
-3.2%
1Y
84.1%
Narrative Update • Jun 04

NKT: Recalibrated Expectations On Power Projects Will Limit Upside Potential

NKT's consensus analyst price target has moved toward DKK 1,070, reflecting a combination of upward revisions, such as the increase to DKK 850, and more cautious views from analysts who now regard the stock as fairly valued at current levels. Analyst Commentary Analysts are split on NKT, with some seeing the current share price as broadly aligned with their targets, while others are flagging less upside and a more balanced risk and reward profile.
COLO B
DKK 386.70
Coloplast
7D
2.3%
1Y
-39.3%
PNDORA
DKK 616.00
Pandora
7D
5.4%
1Y
-48.0%
Narrative Update • Jun 04

PNDORA: Dividend Policy And Margins Will Support Measured Confidence Into 2026

Pandora's analyst price target has been adjusted from about DKK 636.56 to about DKK 616.78, with analysts pointing to updated assumptions for fair value, discount rate, revenue growth, profit margin and future P/E as the key drivers of the change. What's in the News Pandora reaffirmed earnings guidance for fiscal year 2026, with the company expecting an EBIT margin of 21% to 22% (Key Developments).
CARL B
DKK 847.80
Carlsberg
7D
0.7%
1Y
-9.6%
Narrative Update • Jun 02

CARL B: Portfolio Shift And Execution Risks Will Likely Keep Shares Rangebound

Carlsberg's analyst price target is updated to DKK 794.91 from DKK 784.65, as analysts factor in higher assumed revenue growth and profit margins, along with a slightly higher discount rate and a modestly lower future P/E. Analyst Commentary Recent research on Carlsberg shows a mix of optimism around portfolio shifts and more cautious views on what that means for valuation and execution risk.
GMAB
DKK 1,610.50
Genmab
7D
4.3%
1Y
7.7%
ALK B
DKK 264.00
ALK-Abelló
7D
1.0%
1Y
42.9%
Narrative Update • May 29

ALK B: Future Upside Will Come From Allergy Immunotherapy Leadership

Analysts have lifted their price target on ALK-Abelló from DKK 263.33 to DKK 297.50, citing the company’s position as a global leader in allergy immunotherapy and recent supportive research coverage. Analyst Commentary Analysts setting a DKK 305 price target frame ALK-Abelló as a global leader in allergy immunotherapy, and they use that positioning to support a constructive view on the stock’s long term potential.
ORSTED
DKK 160.60
Ørsted
7D
-3.2%
1Y
-42.2%
NSIS B
DKK 383.60
Novozymes
7D
3.3%
1Y
-20.6%